The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Fibrin Deposition in Peyronie's Disease Plaque
Abstract
PURPOSE: Peyronie's disease is a pathological fibrosis characterized by excessive deposition of collagen in the plaque. Although the etiology of Peyronie's disease is unknown, trauma has been hypothesized as the inciting event. In an effort to obtain more insight into the pathogenesis of Peyronie's disease plaque tissue was examined for collagen, elastic fiber, and fibrin content and distribution. MATERIALS AND METHODS: Plaque tissue specimens from 33 patients with Peyronie's disease, control penile tissue and nodular tissue from 8 patients with Dupuytren's contracture were analyzed histochemically for collagen staining and elastic fiber structure and distribution. Plaque tissue from 19 Peyronie's disease patients, control tissue and nodular tissue from Dupuytren's disease were also analyzed for the presence of fibrin by histochemical staining and immunoblotting. RESULTS: Aberrantly stained collagen was detected in 32 of 33 plaque specimens (97%) and disrupted elastic fibers in 31 of the same specimens (94%). Fibrin deposition was detected histochemically in plaque tissue from 18 of 19 patients (95%) but it was not detectable in normal or scarred tunica from control patients. The presence of authentic fibrin accumulation in plaque tissue was confirmed by immunoblot analysis but fibrin was not detected in dermal tissue extracts from the same patient. Aberrant collagen staining and fibrin deposition were detected in nodular tissue from 7 of 8 Dupuytren's contracture patients (88%) and altered elastic fibers in 5 of the same patients (63%). CONCLUSIONS: Deposition of fibrin in plaque tissue is consistent with the hypothesis that repetitive microvascular injury results in fibrin deposition in the tissue space and has served to provide insights into the pathophysiology of Peyronie's disease. We propose a model that accounts for the clinical and biological features of Peyronie's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chromosome Abnormalities in Peyronie’s Disease
Somers, K. D., Winters, B. A., Dawson, D. M., Leffell, M. S., Wright, G. L., Devine, C. J., Gilbert, D. A., & Horton, C. E. (1987) · Journal of Urology · doi:10.1016/s0022-5347(17)44170-x · Cited by 76
Self-citationMultiple clonal chromosome abnormalities in Peyronie's disease
Guerneri, S., Stioui, S., Mantovani, F., Austoni, E., & Simoni, G. (1991) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(91)90461-3 · Cited by 48
Cited by
Peyronie’s Disease: AUA Guideline
Nehra, A., Alterowitz, R., Culkin, D. J., Faraday, M. M., Hakim, L. S., Heidelbaugh, J. J., Khera, M., Kirkby, E., McVary, K. T., Miner, M. M., et al. (2015) · Journal of Urology · doi:10.1016/j.juro.2015.05.098 · Cited by 416
MULHALL, J. P., CREECH, S. D., BOORJIAN, S. A., GHALY, S., KIM, E. D., MOTY, A., DAVIS, R., & HELLSTROM, W. (2004) · Journal of Urology · doi:10.1097/01.ju.0000127744.18878.f1 · Cited by 385
Proposal: Trauma as the Cause of the Peyronie's Lesion
Devine, C. J. J., Somers, K. D., Jordan, G. H., & Schlossberg, S. M. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65361-8 · Cited by 381
Self-citationThe Management of Peyronie’s Disease: Evidence-based 2010 Guidelines
Ralph, D., Gonzalez-Cadavid, N., Mirone, V., Perovic, S., Sohn, M., Usta, M., & Levine, L. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01850.x · Cited by 324
Gonzalez-Cadavid, N. F. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01195.x · Cited by 172
Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease
Gonzalez-Cadavid, N. F., & Rajfer, J. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0201 · Cited by 168
“is supported by histochemical detection of fibrin in human and rat plaque tissue, but not in unaffected tunica albuginea”
BackgroundRisk factors for Peyronie's disease: a case‐control study
BJEKIC, M. D., VLAJINAC, H. D., SIPETIC, S. B., & MARINKOVIC, J. M. (2006) · BJU International · doi:10.1111/j.1464-410x.2006.05969.x · Cited by 154
The Role of Intrinsic Pathway in Apoptosis Activation and Progression in Peyronie’s Disease
Loreto, C., La Rocca, G., Anzalone, R., Caltabiano, R., Vespasiani, G., Castorina, S., Ralph, D. J., Cellek, S., Musumeci, G., Giunta, S., et al. (2014) · BioMed Research International · doi:10.1155/2014/616149 · Cited by 108
The Genetic Basis of Peyronie Disease: A Review
Herati, A. S., & Pastuszak, A. W. (2016) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2015.10.002 · Cited by 104
Davila, H. H., Magee, T. R., Vernet, D., Rajfer, J., & Gonzalez-Cadavid, N. F. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.104.030833 · Cited by 91
Gene expression in Peyronie's disease
Gonzalez-Cadavid, N. F., Magee, T. R., Ferrini, M., Qian, A., Vernet, D., & Rajfer, J. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900873 · Cited by 84
Peyronie’s Disease Intervention Trials: Methodological Challenges and Issues
Müller, A., & Mulhall, J. P. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01081.x · Cited by 80
Role of oxidative stress and antioxidants in Peyronie’s disease
Sikka, S. C., & Hellstrom, W. J. G. (2002) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900880 · Cited by 77
Haag, S. M., Hauck, E. W., Szardening-Kirchner, C., Diemer, T., Cha, E.-S., Weidner, W., & Eickelberg, O. (2007) · European Urology · doi:10.1016/j.eururo.2006.05.002 · Cited by 74
The pathophysiology of Peyronie’s disease
El-Sakka, A. I., Salabas, E., Dinçer, M., & Kadioglu, A. (2013) · Arab Journal of Urology · doi:10.1016/j.aju.2013.06.006 · Cited by 64
Paulis, G., & Brancato, T. (2012) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152812798889321 · Cited by 60
Paulis, G., Romano, G., Paulis, L., & Barletta, D. (2017) · Advances in Urology · doi:10.1155/2017/4653512 · Cited by 44
“Fibrin accumulation also promotes the influx of fibroblasts, already attracted by TGF-ß1 and PDGF [20, 21].”
BackgroundInfluentialSerefoglu, E. C., Smith, T. M., Kaufman, G. J., Liu, G., Yafi, F. A., & Hellstrom, W. J. G. (2017) · Urology · doi:10.1016/j.urology.2017.05.029 · Cited by 39
The potential of platelet-rich plasma injections and stem cell therapy for penile rejuvenation
Israeli, J. M., Lokeshwar, S. D., Efimenko, I. V., Masterson, T. A., & Ramasamy, R. (2022) · International Journal of Impotence Research · doi:10.1038/s41443-021-00482-z · Cited by 30
“This makes it uniquely interesting as a treatment for PD, a disorder of plaques with excessive fibrin and collagen deposition [51].”
BackgroundPeyronie's disease: urologist's knowledge base and practice patterns
Sullivan, J., Moskovic, D., Nelson, C., Levine, L., & Mulhall, J. (2015) · Andrology · doi:10.1111/andr.292 · Cited by 26
Peyronie’s disease: pharmacological treatments and limitations
Li, E. V., Esterquest, R., Pham, M. N., Panken, E. J., Amarasekera, C., Siebert, A., Bajic, P., & Levine, L. A. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1903873 · Cited by 24
Gelbard, M. K., Chagan, L., & Tursi, J. P. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12904 · Cited by 26
Gelbard, M. K., & Rosenbloom, J. (2021) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.195 · Cited by 24
Radiation Increases Fibrogenic Cytokine Expression by Peyronie’s Disease Fibroblasts
MULHALL, J. P., BRANCH, J., LUBRANO, T., & SHANKEY, T. V. (2003) · Journal of Urology · doi:10.1097/01.ju.0000070860.78370.08 · Cited by 22
Role of interleukin‐6 and pentraxin 3 as an early marker in Peyronie's disease
Atar, A., Kural, A., Yenice, G., Comez, I., & Tugcu, V. (2017) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2017.01.007 · Cited by 11
“Although the etiology of PD is not completely explained currently, it is widely accepted that the pathogenesis involves trauma to the erect penis, possibly during intercourse, that leads to fibrin extravasation from the microvessels for the healing of the microtraumatized areas, which in susceptible men results in fib…”
BackgroundDrugs of the future for Peyronie’s disease
Gur, S., Kadowitz, P. J., & Hellstrom, W. J. G. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2011.11.008 · Cited by 10
Current trends in non‐surgical management of Peyronie's disease—A narrative review
Kozub, A., Suleja, A., Chłosta, M., Kupilas, A., Pradere, B., Rivas, J. G., Rajwa, P., & Miszczyk, M. (2024) · Andrology · doi:10.1111/andr.13512 · Cited by 5
Metadata
- Authors
- Somers, K. D., & Dawson, D. M.
- Venue
- Journal of Urology
- Published
- 1997-01
- Volume
- 157
- Issue
- 1
- Pages
- 311-315
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2027064430
- Cited by
- 160
- References
- 2
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.